Industrial Machinery and Supplies and Components

CTN released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 220.53 M, actual EPS CNY -0.2164

CTN to Release FY2026 Q1 Earnings on April 30 After-Market (BJT)

CTN released FY2025 Q4 earnings on April 20 After-Market (BJT), actual revenue CNY -162.81 M, actual EPS CNY -3.467

CTN released FY2025 annual earnings on April 20 After-Market (BJT), actual revenue CNY 470.37 M (forecast CNY 1.642 B), actual EPS CNY -3.22 (forecast CNY 1.05)

CTN to Release FY2025 Earnings on April 25 After-Market (BJT), Forecast Revenue CNY 1.642 B, EPS CNY 1.05

CTN released FY2025 9 Months earnings on October 29 During-Market (BJT), actual revenue CNY 633.19 M, actual EPS CNY 0.2438

CTN released FY2025 Q3 earnings on October 29 During-Market (BJT), actual revenue CNY 225.22 M, actual EPS CNY 0.0593

CTN to Release FY2025 Q3 Earnings Report on October 30 During-Market BJT

CTN released FY2025 Q2 earnings on August 26 After-Market (BJT), actual revenue CNY 218.67 M, actual EPS CNY 0.1345

CTN released FY2025 Semi-Annual earnings on August 26 After-Market (BJT), actual revenue CNY 407.97 M, actual EPS CNY 0.19

CTN to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

Huaxin Securities Publishes Report on Chengyitong

Chengyitong Introduces Integrated Elderly Rehabilitation Solutions

Chengyitong's Brain Link Technology Smart EEG Headband Completes Prototype Development

Chengyitong's Dual-track Layout for Brain-Computer Interface Business and Product Registration Progress

Shanghai State-owned Investment Company Researches Brain-Computer Interface Technology with Ladder Medical

CYT Fully Holds the Founding of an Automation Control Equipment Company

BrainCo Showcases Brain-Computer Interface Technology on Douyin Live Streaming Platform

Chengyitong's Net Profit Fell 59.09% in Q1 2025

Chengyitong Announces 2024 Financial Report and Dividend Plan

300430

688580

Guosen Securities believes that there are significant structural differences between China and the United States in the field of brain-computer interfaces: the U.S. still leads invasive products by 2-5 years, while both countries are basically on par with non-invasive products. Several invasive/semi-invasive clinical trials in China have made milestone progress, and non-invasive products have achieved mass production and overseas certification. The main focus is on two types of targets: leading companies with core technology moats (chips, flexible electrodes, algorithms) and those that have first established a commercial closed loop (rehabilitation medical, consumer electronics)

Wallstreetcn

VISHEE

What is the progress of domestic brain-computer interfaces as overseas prepares for mass production?

CTN announced that its operating revenue in the first half of 2025 was 408 million yuan, a year-on-year decrease of 36.65%. The net profit was 51.1775 million yuan, a year-on-year decrease of 38.76%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves

Zhitong

CTN: Net profit of 51.1775 million yuan in the first half of 2025, a year-on-year decrease of 38.76%

688626

002173

603610

301293

The concept of brain-computer interfaces has seen a surge, with Keeson hitting the daily limit up, followed by increases in VISHEE, Sanbo, CTN, Xiangyu Medical, and Innovative Medical

Xiangyu Medical

Innovative Medical

Keeson

Sanbo

600775

00553

603716

300753

36Kr learned that as of the time of publication, the brain-computer interface concept opened actively, with Thalys achieving a 4-day consecutive limit up, and multiple stocks such as APON, Innovative Medical, NANJING PANDA, Xiangyu Medical, and CTN opening high

36Kr

NPEC

NANJING PANDA

Thalys

APON

The brain-computer interface concept opened actively, Thalys has 4 consecutive boards

Zhongtai Securities released a research report indicating that brain-computer interface (BCI) technology is accelerating from the laboratory to commercialization, with an expected global market increase of approximately $10 billion over the next decade, and the Chinese market is expected to exceed 100 billion yuan. With the advancement of clinical trials and breakthroughs in technological bottlenecks, BCI will achieve commercialization in the medical and consumer electronics fields. Non-invasive brain-computer interfaces dominate the market and are expected to achieve commercialization in the medical field within the next five years

Regencell Bioscience

Stonehill Technology

CASIT

ZHONGTAI SECURITIES

Zhongtai Securities: Domestic and international clinical trials reach a milestone, brain-computer interfaces accelerate from the laboratory to industrialization

CTN stated on the Shenzhen Stock Exchange interactive platform that its subsidiary Brain Link Technology has completed the prototype development of a new generation of smart EEG headbands. This product integrates high-precision EEG signal acquisition and intelligent analysis algorithms, suitable for scenarios such as mental health intervention, children's attention training, and cognitive training for the elderly. In terms of commercialization, the company will continue to optimize product performance and explore application scenarios in medical rehabilitation, smart elderly care, and education based on market demand

CTN: The next-generation smart EEG headband has completed prototype development

300678

002819

Brain-computer interface concept stocks experienced afternoon fluctuations, with APON rising over 10%. BeiYikang, CTN, CASIT, Innovative Medical, OIMEC, and Sanbo also saw gains

OIMEC

300238

Innovative Medical surged to the daily limit, APON rose nearly 10%, and Sanbo, Guanhao Biotech, CTN, Xiangyu Medical, and others had significant gains

Guanhao Biotech

The concept of brain-computer interfaces experiences a surge, Innovative Medical hits the daily limit up

300884

36Kr learned that as of the time of publication, the brain-computer interface concept continues to strengthen, Innovative Medical has reached the daily limit, DNAKE and Keeson had previously hit the limit, APON has risen over 10%, and Xiangyu Medical, CTN, and Zhongke Information are among the top gainers

DNAKE

The concept of brain-computer interfaces continues to strengthen, Innovative Medical hits the limit up

According to the Qichacha APP, recently, Beijing CTN Qinchuan Automation Control Equipment Co., Ltd. was established, with Wei Wei as the legal representative and a registered capital of 1 million yuan. The business scope includes: manufacturing of industrial automation control system devices; sales of industrial automation control system devices; leasing of mechanical equipment, etc. Qichacha's equity penetration shows that the company is wholly owned by CTN

CTN establishes a new company for automation control equipment

CTN(300430.SZ)